WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells.
Chiao-En WuChen-Yang HuangChiao-Ping ChenYi-Ru PanJohn Wen-Cheng ChangJen-Shi ChenChun-Nan YehJohn LunecPublished in: Cancers (2021)
The current study demonstrated that GSK2830371 enhanced the p53-dependent antiproliferative and cytotoxic effect of HDM201 on RBE and SK-Hep-1 cells, providing a novel strategy for potentiating the efficacy of targeting the p53 pathway in iCCA.